Nucleic acid solid-phase synthesis extraction magnetic bead as well as preparation method and application thereof

By modifying ethylene glycol or polyethylene glycol linking arms on the surface of the magnetic beads to form specific DNA sequences, the problem of lack of sequence specificity of existing magnetic beads and low stability of streptavidin-coupled Dynabeads is solved, achieving high efficiency DNA sequence capture and purification, suitable for DNA storage and second-generation sequencing.

CN118904278AInactive Publication Date: 2024-11-08XIANGFU LABORATORY
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
CN202411390370.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-08
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing magnetic beads lack sequence specificity and cannot target the recognition of specific DNA sequences, and the dissociation conditions of streptavidin-coupled Dynabeads are harsh and have low stability.

Method used

Magnetic beads formed by silica or polymer wrapped in iron tetroxide are used to modify ethylene glycol or polyethylene glycol connecting arms on the surface of the magnetic beads through solid phase synthesis technology to form a specific DNA sequence to achieve specific capture of DNA.

Benefits of technology

The number of specific nucleic acids on the surface of the magnetic beads is significantly improved, the operation complexity is simplified, and the high load specific DNA sequence tag magnetic beads are obtained, ensuring high recovery and enrichment rates, suitable for DNA storage and purification of second-generation sequencing samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118904278A_ABST
    Figure CN118904278A_ABST
Patent Text Reader

Abstract

The invention provides a nucleic acid solid-phase synthesis extraction magnetic bead as well as a preparation method and application thereof. The preparation method comprises the following steps: 1) providing a magnetic bead formed by coating ferroferric oxide with silicon dioxide or a polymer; 2) modifying a connecting arm on the surface of the magnetic bead, wherein the tail end of the connecting arm is provided with a hydroxyl group or a hydroxyl group with a protecting group; 3) connecting four different nucleic acid base monomers to the magnetic bead carrier according to a specified sequence through a solid-phase synthesis technology to form a nucleic acid DNA sequence with a certain length; and 4) removing the protecting group on the nucleic acid base monomer to obtain the nucleic acid solid-phase synthesis extraction magnetic bead with the specific DNA sequence. The nucleic acid solid-phase synthesis extraction magnetic bead prepared by the method can be used for specifically combining a terminal target DNA sequence and capturing the terminal target DNA sequence, so that a target cluster of pure DNA products is selectively separated, extremely high recovery rate and enrichment rate are ensured, and the magnetic bead has a good application prospect in DNA storage.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of DNA solid phase synthesis, and more specifically to a nucleic acid solid phase synthesis extraction magnetic bead and a preparation method and application thereof. Background Art

[0002] DNA data storage first encodes digital information into a DNA sequence, then uses a chip for high-throughput synthesis, stores the synthesized DNA fragments on the chip or introduces the synthetic gene into cells; retrieves and selectively reads the sequence information; and uses sequencing to convert the sequenced DNA sequence back into digital information.

[0003] There are up to one million channels on a DNA synthesis chip. Under certain circumstances, the more DNA is synthesized on a chip at the same time, the lower the cost. However, sometimes it is necessary to extract the sequences that are completely synthesized and have specific retrieval tags on the ends, which requires capture and extraction.

[0004] After the construction of the second-generation sequencing library and the addition of adapters, the library system contains various enzymes such as polymerase, ligase, and auxiliary substances. The addition of adapters is also excessive, and due to the instability of the ends, self-ligated fragments are easily formed. Therefore, special magnetic beads (AMPure XP Beads) are required for purification to remove large fragments and various impurities, so as to obtain library fragments with successful addition of adapters.

[0005] In addition, the fragments need to be added with specific label indexes for distinguishing different libraries, as well as two oligonucleotide sequence connectors that are complementary to the sequencer chip. They are then amplified with primers complementary to the connectors. After PCR, the product DNA fragments need to be separated from impurities such as polymerase, so they are purified by magnetic beads again, followed by quality testing to complete the library construction.

[0006] In view of the above situation, the existing magnetic beads themselves do not have the ability to select targeted fragment sizes. The principle is that magnetic beads can adsorb DNA fragments through hydrogen bonds and other forces. Purification magnetic beads are usually stored in a buffer containing 20% ​​PEG 8000. The higher the PEG concentration, the smaller the adsorbed DNA fragments. Therefore, when using magnetic beads for purification, it is necessary to strictly control the amount of magnetic beads added (actually the amount of PEG added) according to different library fragments to achieve the selection of DNA fragments of different sizes, but such DNA fragments do not have sequence specificity.

[0007] Streptavidin-coupled Dynabeads magnetic beads are a powerful and versatile tool that can be used to capture specific RNA or DNA sequences and then extract them directly from solution. The specific sequence is fixed to the Dynabeads magnetic beads through the streptavidin-biotin bond. Although the biotin-streptavidin system provides extremely high binding force, its dissociation conditions are relatively harsh and are not suitable for all types of samples or subsequent analysis. Changes in environmental factors such as temperature, pH, and salt concentration may affect the performance and stability of the magnetic beads. Summary of the invention

[0008] The purpose of the present invention is to provide a nucleic acid solid phase synthetic extraction magnetic beads and a preparation method and application thereof, so as to solve the problems in the prior art that ordinary magnetic beads do not have sequence specificity and cannot target and recognize specific DNA sequences, and that the dissociation conditions of streptavidin-coupled Dynabeads magnetic beads are relatively harsh and the stability is relatively low.

[0009] In order to solve the above problems, the present invention adopts the following technical solutions: According to a first aspect of the present invention, a method for preparing magnetic beads for solid phase synthesis extraction of nucleic acids is provided, comprising the following steps: 1) providing magnetic beads formed by silicon dioxide or by encapsulating ferrosoferric oxide with a polymer; 2) modifying the surface of the magnetic beads with a linker composed of ethylene glycol or polyethylene glycol, wherein the end of the linker carries a hydroxyl group or a hydroxyl group with a protective group; 3) placing the magnetic bead carrier obtained in step 2) into a synthesis column, and connecting four different nucleic acid base monomers to the magnetic bead carrier in a specified order through solid phase synthesis technology to form a nucleic acid DNA sequence of a certain length; 4) removing the protective groups on the nucleic acid base monomers to obtain a nucleic acid solid phase synthesis extraction magnetic bead with a specific DNA sequence.

[0010] According to the method provided by the present invention, the magnetic beads are first transformed into long connecting arms with hydroxyl groups or hydroxyl groups with protecting groups at the ends to provide binding sites for nucleic acid synthesis, thereby directly constructing specific nucleic acid sequences on the magnetic bead carriers through solid phase synthesis technology. Solid phase synthesis itself is a commonly used technology, but the present invention applies it to magnetic bead carriers with specific designs, and synthesizes nucleic acid sequences in a specified order, which can significantly increase the number of specific nucleic acids on the surface of the magnetic beads and reduce the complexity of pre-synthesizing sequences and then connecting them, thereby obtaining a magnetic bead with a high-load specific DNA sequence tag, which has significant advantages over the prior art.

[0011] Preferably, in step 1), the polymer may be selected from polystyrene, polyamide, polyethylene glycol, etc. It should be understood that magnetic beads formed by encapsulating ferrosoferric oxide with silicon dioxide or polymer are commercially available.

[0012] Preferably, in step 2), the surface of the magnetic beads is modified with an alkali-resistant linker arm such as ethylene glycol or polyethylene glycol or a long-chain alkyl, and the end of the linker arm has a hydroxyl group or a hydroxyl group with a protecting group, wherein the protecting group is dimethoxytrityl (DMT) or monooxytrityl (MMT).

[0013] Preferably, step 2) comprises: washing and drying the magnetic beads, suspending them in a mixture of xylene, 3-propyloxytrimethoxysilane and a trace amount of N,N-diisopropylethylamine, washing them with methanol and ether, air-drying them, drying them, stirring and heating them in a mixture of hexaethylene glycol and a small amount of concentrated sulfuric acid at 80°C overnight, washing them with methanol and ether, and vacuum drying them to obtain an alkylhydroxyl-modified magnetic bead carrier.

[0014] Preferably, step 3) includes the following sub-steps: 3.1) Deprotection: adding a deprotection reagent to remove the hydroxyl protecting group of the magnetic bead carrier or the base, and washing with acetonitrile; 3.2) Coupling: adding ethylthiotetrazole as an activator, adding the phosphoramidite monomer to the magnetic bead carrier in the synthesis column, extending the DNA chain, and washing with acetonitrile; 3.3) Blocking: adding a blocking reagent to acetylate the incompletely reacted hydroxyl group, and washing with acetonitrile; 3.4) Oxidation: adding an oxidant to oxidize trivalent phosphorus to pentavalent phosphorus; these four steps are cyclically performed during DNA synthesis, and each cycle adds a new nucleotide to the DNA chain.

[0015] Preferably, the deprotection reagent used in step 3.1) includes: DCA (dichloroacetic acid), TCA (trichloroacetic acid) or benzoic acid.

[0016] Preferably, the phosphoramidite monomers used in step 3.2) include: ordinary DNA monomers such as DMT-dT-CEPhosphoramidite, DMT-dC-CE Phosphoramidite, DMT-dA-CE Phosphoramidite, and DMT-dG-CE Phosphoramidite; 2'-O-Me (methyl) modified monomers such as DMT-2'-O-Me-T-CEPhosphoramidite, DMT-2'-O-Me-C-CE Phosphoramidite, DMT-2'-O-Me-A-CEPhosphoramidite, DMT-2'-O-Me-G-CE Phosphoramidite; DMT-2'-F-dA-CE-Phosphoramidite, DMT-2'-F-dG-CE-Phosphoramidite, DMT-2'-F-dC-CE-Phosphoramidite, DMT-2'-F-dT-CE-Phosphoramidite; also includes other stable modified nucleic acid monomers, such as LNA (locked nucleic acid) monomers, etc.

[0017] Preferably, step 4) comprises: removing the protecting groups on the nucleic acid base monomers by deprotection by ammonia, thereby obtaining a nucleic acid solid phase synthesis extraction magnetic bead with a specific DNA sequence. In addition to deprotection by ammonia hydrolysis, deprotection by organic bases such as tert-butanolamine, diethylamine, triethylamine, methylamine, etc., and deprotection by alkaline solution, such as a methanol solution of potassium carbonate, etc. can also be used.

[0018] Preferably, the method further comprises: synthesizing a reference magnetic bead while synthesizing the target magnetic bead, the difference between the preparation methods of the reference magnetic bead and the target magnetic bead is that in the first cycle, the Chemical Phosphorylation Reagent II phosphoramidite monomer is used in the coupling sub-step, and from the second cycle onwards, the synthesis is carried out according to the specified DNA sequence. After completion, during aminolysis in a gas phase aminolysis instrument, the DNA sequence on the reference magnetic beads will be cut off, while the sequence on the target magnetic beads will not be cut off.

[0019] Preferably, the quality of the synthetic product can be detected by drying the synthetic column after aminolysis, using a syringe to push acetonitrile to clean it multiple times, then eluting the synthetic column with deionized water, collecting the eluate, and measuring the absorbance using an ultra-micro spectrophotometer.

[0020] According to a second aspect of the present invention, there is provided a nucleic acid solid phase synthesis extraction magnetic bead prepared according to the above preparation method, which can selectively capture DNA of a specified sequence, and the DNA sequence on the nucleic acid solid phase synthesis extraction magnetic bead is complementary to the base of the DNA sequence to be captured.

[0021] According to a third aspect of the present invention, there is provided a use of nucleic acid solid phase synthesis extraction magnetic beads in DNA storage.

[0022] According to the present invention, a solid-phase nucleic acid synthesis and extraction magnetic bead is provided, which is composed of ferrosoferric oxide wrapped by silica or polymer (polystyrene; polyamide; polyethylene-ethylene glycol, etc.), and a connecting arm (composed of ethylene glycol or polyethylene glycol) is modified on the surface of the silica or polymer, and the end of the connecting arm is composed of a hydroxyl group or a hydroxyl group with a protecting group (dimethoxytrityl DMT or monooxytrityl MMT). Through solid-phase synthesis technology, four different nucleic acid base monomers (A, G, C, U, or dA, dG, dC, dT) are connected to the above-mentioned magnetic bead carrier in a specified order to form a nucleic acid sequence of a certain length. The protecting groups on the nucleic acid monomers are removed by deprotection to synthesize a magnetic bead with a specific nucleic acid sequence, and the magnetic bead can selectively capture DNA of the specified sequence.

[0023] It should be understood that in the prior art, solid phase synthesis mostly relies on resin or silica carriers, which are only used as carriers for synthesis. The present invention creatively transforms the magnetic beads into long connecting arms with hydroxyl groups or hydroxyl groups with protecting groups at the ends for the first time, providing binding sites for nucleic acid synthesis, through which four different nucleic acid base monomers are sequentially connected to the magnetic bead carrier. The magnetic beads after solid phase synthesis of nucleic acids in this method can be conveniently separated by an external magnetic field, which greatly simplifies the synthesis and purification process and makes it easier to produce more stable specific extraction magnetic beads.

[0024] In summary, the nucleic acid solid phase synthetic extraction magnetic beads provided by the present invention can be used to specifically bind to the terminal target DNA sequence and capture it, thereby selectively separating a cluster of target DNA pure products, ensuring extremely high recovery and enrichment rates. For second-generation sequencing samples, the fragments can be purified twice through specific magnetic beads with two different linker sequences to complete the library construction, which has good application prospects in DNA storage. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 Schematic diagram of nucleic acid solid phase synthesis extraction magnetic beads prepared according to the method of the present invention and reference magnetic beads; wherein the gray sphere represents the magnetic bead carrier, OLIGO is the synthesized oligonucleotide sequence; a is the connection structure of nucleic acid solid phase synthesis extraction magnetic beads prepared according to the method of the present invention; b is the connection structure of the reference magnetic beads, and the dotted line position of this structure will break during aminolysis; Figure 2The figure is a mass spectrum of nucleic acid solid phase synthesis extraction magnetic beads prepared according to the method of the present invention. DETAILED DESCRIPTION

[0026] The present invention is further described below in conjunction with specific examples. It should be understood that the following examples are only used to illustrate the present invention and are not used to limit the scope of the present invention. The raw materials and instruments used in the following examples are all commercially available; the equipment and preparation processes used are conventional equipment and conventional processes unless otherwise specified.

[0027] Example 1 Preparation of a nucleic acid solid phase synthesis extraction magnetic bead instrument: Nucleic acid synthesizer A&K-28.

[0028] Step 1: Provide a magnetic bead formed by silicon dioxide or polymer-encapsulated ferroferric oxide This embodiment uses a kind of silicon hydroxy nano magnetic beads purchased from Xi'an Qiyue Biotechnology Co., Ltd. The magnetic core of the magnetic beads is Fe3O4 and the surface is covered with SiO2.

[0029] Step 2: Prepare a magnetic bead carrier 2.1 After washing the silicon hydroxy nanoparticles with deionized water, methanol and ether, air-drying and vacuum drying, the dried magnetic beads (1 g) were suspended in a mixture of xylene (4 mL), 3-propyloxytrimethoxysilane (1 mL) and trace amounts of N,N-diisopropylethylamine, stirred overnight at 80 °C, and then washed with methanol and ether, air-dried and vacuum-dried. A magnetic bead with a surface modified with a connecting arm was obtained.

[0030] 2.2 The magnetic beads modified in the previous step were stirred and heated in a mixture of hexaethylene glycol and a small amount of concentrated sulfuric acid at 80°C overnight. After washing with methanol and ether, air drying, and then vacuum drying, alkylhydroxyl-modified magnetic bead carriers were obtained. The long-chain alkyl on the surface of the magnetic beads was used as a connecting arm, and the terminal was a hydroxyl group, so as to be used for phosphoramidite synthesis.

[0031] Step 3: Solid-phase synthesis of nucleic acids on magnetic bead carriers To capture the universal linker sequence 5'-AGATGTGTATAAGAGACAG-3', the pre-synthesized complementary sequence in this embodiment is 5'-CTGTCTCTTATACACATCT-3' (SEQ ID No. 1), and the synthesis direction is 3'-5'. It should be understood that the present invention is not actually limited to capturing 5'-AGATGTGTATAAGAGACAG-3', which is only shown here as an example of a universal linker sequence.

[0032] Place 10 mg of magnetic bead carrier into the synthesis column. In order to improve the reaction efficiency, in the coupling reaction step, the phosphoramidite monomers used were dT-CEPhosphoramidite, dC-CE Phosphoramidite, dA-CE Phosphoramidite, and dG-CE Phosphoramidite, and were prepared into 0.15 M solutions with acetonitrile. The coupling reaction time was 300 seconds. The synthesis of a DNA sequence was completed through 19 cycles, and the synthesis column was numbered 1. The synthesis is divided into four steps, including deprotection, coupling, capping (closing) and oxidation.

[0033] 3.1 Deprotection: Add deprotection reagent (5% dichloroacetic acid in dichloromethane) to remove the magnetic bead carrier (if there is a protecting group DMT or MMT) or the hydroxyl protecting group (DMT) of the nucleoside, and wash with acetonitrile; 3.2 Coupling: Add 0.75 M concentration of ethylthiotetrazolyl (ETT) as an activator, then add the phosphoramidite monomer to the magnetic bead carrier in the synthesis column, extend the DNA chain, and wash with acetonitrile; 3.3 Blocking: Add blocking reagents CAP A and CAP B to block the unreacted nucleotides to reduce the generation of sequences with intermediate missing bases, and wash with acetonitrile; 3.4 Oxidation: Add an oxidant to oxidize trivalent phosphorus into pentavalent phosphorus.

[0034] It should be understood that these four steps are cyclically performed during DNA synthesis, with each cycle adding a new base to the DNA chain. After the synthesis is completed, a deprotection step is used to remove the protecting group DMT on the terminal hydroxyl group.

[0035] In order to understand the quality of the synthesized product, this embodiment also includes synthesizing a nucleic acid sequence that can be cut for reference during the synthesis of synthesis column 1, and this synthesis column is numbered 2, i.e., synthesis column 2. In the synthesis of synthesis column 2, during the first cycle, the phosphoramidite monomer used for connection is Chemical Phosphorylation Reagent II, and from the second cycle onwards, it is synthesized according to the sequence 5'-CTGTCTCTTATACACATCT-3'. After the synthesis is completed, synthesis column 1 is still on the magnetic bead carrier, and the first position on synthesis column 2 will be cut and broken by ammonia due to the special structure of Chemical Phosphorylation Reagent II, and the synthesized nucleic acid will fall off. The reaction mechanism is as follows Figure 1 shown.

[0036] Step 4: Prepare a nucleic acid solid phase synthesis extraction magnetic bead with a specific DNA sequence After the synthesis is completed, put the synthesis column 1 and the synthesis column 2 into the gas phase ammonolysis instrument, add concentrated ammonia water and heat to 65°C for at least three hours. After the synthesis column is dried, use a syringe to push acetonitrile to clean it three times, then elute the synthesis column with deionized water, collect the eluate, and use an ultra-micro spectrophotometer to measure the absorbance. The eluate of the synthesis column 1 has almost no absorbance at 260nm. The absorbance of the control synthesis column 2 is converted according to 19bp 5.5nm / OD, and the calculated synthesis amount is about 1.9 μM. The mass spectrometry detected molecular weight is 5768.8, and the calculated molecular weight of 5'-CTGTCTCTTATACACATCT-3' is 5688.8. During the aminolysis, due to the addition of one phosphoric acid, the molecular weight increases by 80, so the actual molecular weight after cutting is 5768.8. The results are as follows Figure 2 As shown, the highest peak is the target molecular weight 5768.8.

[0037] The above is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention. The above embodiments of the present invention can also be modified in various ways. All simple, equivalent changes and modifications made according to the claims and the description of the present invention fall within the scope of protection of the claims of the present invention. The contents not described in detail in the present invention are all conventional technical contents.

Claims

1. A method for preparing magnetic beads for solid phase synthesis and extraction of nucleic acids, characterized in that: The following steps are involved: 1) providing a magnetic bead formed by silicon dioxide or polymer-encapsulated ferrosoferric oxide; 2) modifying the surface of the magnetic bead with a connecting arm composed of ethylene glycol, polyethylene glycol or a long-chain alkyl, wherein the end of the connecting arm has a hydroxyl group or a hydroxyl group with a protective group; 3) placing the magnetic bead carrier obtained in step 2) into a synthesis column, and connecting four different nucleic acid base monomers to the magnetic bead carrier in a specified order through solid phase synthesis technology to form a nucleic acid DNA sequence of a certain length; 4) removing the protective group on the nucleic acid base monomer through deprotection, thereby obtaining a nucleic acid solid phase synthesis extraction magnetic bead with a specific DNA sequence.

2. The preparation method according to claim 1, characterized in that: In step 1), the polymer is any one of polystyrene, polyamide, and polyethylene glycol.

3. The preparation method according to claim 1, characterized in that: Step 2) comprises: washing and drying the magnetic beads, suspending them in a mixture of xylene, 3-propyloxytrimethoxysilane and a trace amount of N,N-diisopropylethylamine, washing them with methanol and ether, air-drying them, drying them, stirring and heating them in a mixture of hexaethylene glycol and a small amount of concentrated sulfuric acid at 80°C overnight, washing them with methanol and ether, and vacuum drying them to obtain an alkylhydroxyl-modified magnetic bead carrier.

4. The preparation method according to claim 1, characterized in that: Step 3) includes the following sub-steps: 3.1) Deprotection: Add deprotection reagent to remove the hydroxyl protecting group of the magnetic bead carrier or base, and wash with acetonitrile; 3.2) Coupling: Add ethylthiotetrazolyl as an activator, add the phosphoramidite monomer to the magnetic bead carrier in the synthesis column, extend the DNA chain, and wash with acetonitrile; 3.3) Blocking: Add blocking reagent to acetylate the unreacted hydroxyl groups and wash with acetonitrile; 3.4) Oxidation: Add an oxidant to oxidize trivalent phosphorus into pentavalent phosphorus; These four steps are repeated in cycles during DNA synthesis, with each cycle adding a new nucleotide to the DNA chain.

5. The preparation method according to claim 4, characterized in that The phosphoramidite monomers used in step 3.2) include: unmodified DNA monomers, 2'-O-Me modified monomers, or LNA monomers.

6. The preparation method according to claim 1, characterized in that: The deprotection in step 4) is carried out using any one of the following reagents, including: aqueous ammonia, tert-butanolamine, diethylamine, triethylamine, methylamine, or a methanol solution of potassium carbonate.

7. The preparation method according to claim 4, characterized in that The method further includes: synthesizing a reference magnetic bead while synthesizing the target magnetic bead. The difference between the preparation methods of the reference magnetic bead and the target magnetic bead is that in the first cycle, the Chemical Phosphorylation Reagent II is used in the coupling sub-step, and from the second cycle onwards, the synthesis is carried out according to the specified DNA sequence. After completion, during aminolysis in a gas phase aminolysis instrument, the DNA sequence on the reference magnetic bead will be cut off, while the sequence on the target magnetic bead will not be cut off.

8. The preparation method according to claim 7, characterized in that: The quality of the synthetic product can be detected by drying the synthetic column after aminolysis, using a syringe to push acetonitrile into it for cleaning multiple times, then eluting the synthetic column with deionized water, collecting the eluate, and measuring the absorbance using an ultra-micro spectrophotometer.

9. A nucleic acid solid phase synthesis extraction magnetic bead prepared according to the preparation method according to any one of claims 1 to 8, which can selectively capture DNA of a specified sequence, and the DNA sequence on the nucleic acid solid phase synthesis extraction magnetic bead is complementary to the base pair of the DNA sequence to be captured.

10. Use of the nucleic acid solid phase synthesis extraction magnetic beads according to claim 9 in DNA storage.

Citation Information

Patent Citations

  • High throughput nucleic acid sequencing by expansion

    CN102083998A

  • Nucleic acid purification method

    CN102421898A

  • Compound immobilization method for acetylcholine esterase

    CN106011126A

  • Gene chip for nucleic acid enrichment extraction and preparing method thereof

    CN108048916A

  • Nucleic acid synthesis solid phase carrier, preparation method, nucleic acid synthesis device containing carrier and nucleic acid synthesis method

    CN108728431A